HHS (Harte-Hanks) Intrinsic Value: Projected FCF: $2.87 (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HHS Harte-Hanks Inc HHS
61 GF Score
Price $4.64
GF Value $4.13
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Harte-Hanks Intrinsic Value: Projected FCF?

Harte-Hanks HHS +1.53% 61 Intrinsic Value: Projected FCF is $2.87 as of Sep. 17, 2026. GuruFocus rates HHS with a GF Score™ of 61/100 and a GF Value™ of $4.13 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 418 Conglomerates companies, Harte-Hanks ranks worse than 73.92% on this metric.

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2026-09-17), Harte-Hanks's Intrinsic Value: Projected FCF is $2.87. The stock price of Harte-Hanks is $4.64. Therefore, Harte-Hanks's Price-to-Intrinsic-Value-Projected-FCF of today is 1.6.

The historical rank and industry rank for Harte-Hanks's Intrinsic Value: Projected FCF or its related term are showing as below:

HHS' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.15   Med: 0.7   Max: 3.1
Current: 1.62

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Harte-Hanks was 3.10. The lowest was 0.15. And the median was 0.70.

HHS's Price-to-Projected-FCF is ranked worse than
73.92% of 418 companies
in the Conglomerates industry
Industry Median: 0.87 vs HHS: 1.62

Harte-Hanks  (NAS:HHS) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Harte-Hanks's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=4.64/4.0558008797974
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Harte-Hanks Intrinsic Value: Projected FCF Related Terms


Harte-Hanks Intrinsic Value: Projected FCF Historical Data

* Premium members only.

The historical data trend for Harte-Hanks's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harte-Hanks Intrinsic Value: Projected FCF Chart

Harte-Hanks Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Harte-Hanks Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HHS vs GPUS, LGPS, PLAG: Intrinsic Value: Projected FCF Comparison

For the Conglomerates subindustry, Harte-Hanks's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harte-Hanks Price-to-Projected-FCF vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Harte-Hanks's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Harte-Hanks's Price-to-Projected-FCF falls into.


HHS
61GF Score
Harte-Hanks Inc HHS
Intrinsic Value: Projected FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harte-Hanks Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Harte-Hanks's Free Cash Flow(6 year avg) = $1.88.

Harte-Hanks's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun26)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*1.87584+15.35*0.8)/7.431
=4.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Intrinsic Value: Projected FCF of $2.87 mean?
Harte-Hanks (HHS) has a Intrinsic Value: Projected FCF of $2.87 as of Sep. 17, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Harte-Hanks and its competitors. According to the industry distribution chart, Harte-Hanks ranks #309 out of 418 companies in the Conglomerates industry, placing it in the top 73.9%.
Is Harte-Hanks' Intrinsic Value: Projected FCF too high?
Harte-Hanks' current Intrinsic Value: Projected FCF is $2.87. The Conglomerates industry median Intrinsic Value: Projected FCF is 0.87. Harte-Hanks' value of $2.87 is 229.9% above this industry median. Based on the distribution chart, Harte-Hanks ranks #309 out of 418 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Harte-Hanks has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Harte-Hanks' Intrinsic Value: Projected FCF compare to GPUS and LGPS?
According to the Conglomerates industry distribution chart, Harte-Hanks ranks #309 out of 418 companies for Intrinsic Value: Projected FCF. This places Harte-Hanks in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 0.87. Harte-Hanks' value of $2.87 is 229.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Conglomerates company?
The median Intrinsic Value: Projected FCF among Conglomerates companies is 0.87, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Harte-Hanks's current Intrinsic Value: Projected FCF of $2.87 is 229.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Harte-Hanks and its competitors. For the Conglomerates industry, the median Intrinsic Value: Projected FCF is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harte-Hanks's current Intrinsic Value: Projected FCF is $2.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harte-Hanks stock overvalued right now?
Based on GuruFocus' analysis, Harte-Hanks (HHS) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.13, compared to a current price of $4.64 — trading 12.3% above its estimated fair value. The current Intrinsic Value: Projected FCF is $2.87 and 229.9% above the Conglomerates industry median of 0.87. Harte-Hanks' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Harte-Hanks (HHS), the current Intrinsic Value: Projected FCF is $2.87 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harte-Hanks (HHS) Overvalued in 2026?

Based on GuruFocus' analysis, Harte-Hanks stock appears to be overvalued. The current stock price of $4.64 is trading 12.3% above its estimated GF Value™ of $4.13. GuruFocus considers Harte-Hanks to be Modestly Overvalued.

Key valuation signals for HHS:

  • Intrinsic Value: Projected FCF: $2.87
  • GF Value™: $4.13 vs. price of $4.64 (12.3% above fair value)
  • GF Score™: 61/100 with 5 warning signs
  • Industry Position: 229.9% above the Conglomerates median (#309 of 418)

No single metric tells the full story. See the HHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Harte-Hanks Business Description

Other Exchanges HHK1:Germany
Address 1 Executive Drive, Chelmsford, MA, USA, 01824
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
61GF Score

Get the complete analysis for HHS

Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.64
Price
$4.13
GF Value